Research
Extension Study Demonstrates Durable Benefits of Stanza for Fibromyalgia
Swing Therapeutics announced today the follow-up results from the PROSPER-FM study of Stanza, demonstrating the durability of the treatment for…
Read this Article >Category: Research
Research
Stanza Shows Lasting Benefits for Fibromyalgia Symptoms in 12-Month Extension Study
Swing Therapeutics announced new data on the long-term durability of Stanza, a digital behavioral therapy for the treatment of fibromyalgia…
Read this Article >Press Releases
Swing Therapeutics Announces The Lancet Publication of Data from Phase 3 Trial of Stanza™ – a Digital Behavioral Therapy for Fibromyalgia Symptoms
Stanza demonstrated significant improvements compared to an active control on virtually all endpoints, including fibromyalgia-related well-being, pain intensity, pain interference,…
Read this Article >
Research
Stanza Digital Behavioral Therapy Shown to Address Fibromyalgia Patient Unmet Needs
This month, Swing Therapeutics presented data from a real-world trial of Stanza, an FDA-cleared digital behavioral therapy for treatment of…
Read this Article >
Research
Swing Announces Positive Early Results from Specialty Fibromyalgia Clinic
This week, Swing announced early outcomes from Swing Care, a specialty clinic dedicated to comprehensive, evidence-based fibromyalgia treatment. The results…
Read this Article >
Research
Swing Therapeutics Announces Long-Term Effectiveness Data from Studies of Stanza
Swing Therapeutics, a digital therapeutics company developing evidence-backed treatments for chronic pain conditions, announced the publication of new research data…
Read this Article >
Recent Comments